Zacks cuts Tenet estimate as Tenet Healthcare stock awaits results
Published on 10/20/2026 at 14:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEstimate revisions and operating outlook
- Zacks cut its 2027 earnings estimate to USD 5.12 from USD 5.13 on October 16, 2026.
- Tenet raised adjusted EBITDA guidance to USD 4.83 billion to USD 5.03 billion on September 24, 2026.
- Tenet Healthcare stock traded at EUR 238.00 at 2:10 p.m. CEST at Lang & Schwarz on October 20, 2026.
Tenet Healthcare stock (ISIN US88033G4073) was quoted at EUR 238.00 at Lang & Schwarz on October 20, 2026 at 2:10 p.m. CEST, while Zacks Research cut its fourth-quarter 2027 earnings-per-share estimate to USD 5.12 from USD 5.13. The revision was dated October 16, 2026, according to MarketBeat.
Estimate cut sharpens the earnings focus
The reduction was small in absolute terms, but it puts the October 29 results date at the center of the near-term setup. MarketBeat reported that Zacks maintained a Hold rating and placed the full-year consensus earnings estimate at USD 21.04 per share on October 19, 2026.
Tenet had delivered adjusted earnings per share of USD 6.12 against a USD 4.26 consensus estimate in the second quarter of 2026, while revenue reached USD 6.04 billion and increased 6.80 percent from the prior-year quarter, according to MarketBeat.
What does the outlook mean for margins?
Tenet raised its 2026 adjusted EBITDA guidance to USD 4.83 billion to USD 5.03 billion on September 24, 2026. Zacks said second-quarter revenue increased 6.80 percent to USD 5.63 billion, while hospital adjusted EBITDA rose 22.30 percent to USD 762.00 million. The company also reported a 1.20 percent year-over-year decline in USPI surgical cases, making revenue per case and service mix important operating variables.
Three dates frame the stock
On July 24, 2026, Barclays raised its target from USD 240.00 to USD 271.00, according to MarketBeat. On September 24, 2026, Zacks cited adjusted EBITDA guidance of USD 4.83 billion to USD 5.03 billion. On October 16, 2026, Zacks cut its estimate from USD 5.13 to USD 5.12.
Next reporting date is October 29
Tenet is scheduled to report third-quarter 2026 results before the market opens on October 29, 2026, according to Simply Wall St. The release will test whether the higher adjusted EBITDA outlook can offset softer procedure volumes.
Tenet Healthcare stock stays tied to guidance
Tenet Healthcare Corporation operates hospitals, ambulatory surgery centers and related healthcare services, with United Surgical Partners International as a major operating platform. Its investor-relations page identifies the company as listed on the NYSE under THC.
The stock was trading at EUR 238.00 at Lang & Schwarz on October 20, 2026 at 2:10 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Tenet Healthcare stock.
Tenet Healthcare at a glance
- Company: Tenet Healthcare Corporation
- ISIN: US88033G4073
- Ticker: THC
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 2:10 p.m. CEST): EUR 238.00
- Market capitalization: USD 21.4 billion (as of October 19, 2026)
- 52-week range: USD 157.58-283.05 (as of October 19, 2026)
- Sector / Industry: Health Care / Health Care Providers and Services
- Next earnings date: October 29, 2026
Market context: Market report S&P 500.
